On December 3rd 2025 it was announced that KALDUR therapeutics had obtained a funding offer from Kría – The New Business Venture Fund. The funding offer followed a funding round where 88 companies applied for funding and 22 were invited for further discussion, from which 11 were choosen for funding offer.
The offer is contingent on KALDUR obtaining matching funds from investors. We are now actively seeking investors interested in participating in this funding round, with plans to complete the round prior to February 28th 2026.
If you are interested in discussing funding with us, please contact us via email (martiningi@gmail.com or hbjorns1@gmail.com).
We are grateful for the confidence demonstrated by the funding offer from Kría.
https://www.nyskopun.is/en/frettir/nyskopunarsjodurinn-kria-fjarfestir-i-11-sprotafyrirtaekjum
KALDUR Therapeutics 
Leave a comment